keyword
https://read.qxmd.com/read/37189112/structural-and-non-structural-proteins-in-sars-cov-2-potential-aspects-to-covid-19-treatment-or-prevention-of-progression-of-related-diseases
#41
REVIEW
Sareh Kakavandi, Iman Zare, Maryam VaezJalali, Masoud Dadashi, Maryam Azarian, Abdullatif Akbari, Marzieh Ramezani Farani, Hamidreza Zalpoor, Bahareh Hajikhani
Coronavirus disease 2019 (COVID-19) is caused by a new member of the Coronaviridae family known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There are structural and non-structural proteins (NSPs) in the genome of this virus. S, M, H, and E proteins are structural proteins, and NSPs include accessory and replicase proteins. The structural and NSP components of SARS-CoV-2 play an important role in its infectivity, and some of them may be important in the pathogenesis of chronic diseases, including cancer, coagulation disorders, neurodegenerative disorders, and cardiovascular diseases...
May 15, 2023: Cell Communication and Signaling: CCS
https://read.qxmd.com/read/37079062/drug-repositioning-doxazosin-attenuates-the-virulence-factors-and-biofilm-formation-in-gram-negative-bacteria
#42
JOURNAL ARTICLE
Mahmoud A Elfaky, Samar S Elbaramawi, Ahmed G Eissa, Tarek S Ibrahim, El-Sayed Khafagy, Mohamed A M Ali, Wael A H Hegazy
The resistance development is an increasing global health risk that needs innovative solutions. Repurposing drugs to serve as anti-virulence agents is suggested as an advantageous strategy to diminish bacterial resistance development. Bacterial virulence is controlled by quorum sensing (QS) system that orchestrates the expression of biofilm formation, motility, and virulence factors production as enzymes and virulent pigments. Interfering with QS could lead to bacterial virulence mitigation without affecting bacterial growth that does not result in bacterial resistance development...
April 20, 2023: Applied Microbiology and Biotechnology
https://read.qxmd.com/read/37067186/adverse-events-related-to-alpha-blockers-analysis-of-real-life-data-from-eudra-vigilance
#43
JOURNAL ARTICLE
Antonio Cicione, Antonio Nacchia, Valeria Baldassarri, Giorgia Tema, Lorenzo M Rovesti, Elisa Mancini, Giorgio Guarnotta, Olivia A Voglino, Antonio Franco, Simone D'Annunzio, Riccardo Lombardo, Andrea Tubaro, Cosimo DE Nunzio
BACKGROUND: Patients on alpha-blockers (ABs) treatment may have an increased risk of adverse events (AEs). Aim of our study was to compare real-life data on neuro-vascular and sexual AEs associated with ABs based on Eudra-Vigilance reported AEs. METHODS: Eudra-Vigilance (EV) database is the system for managing and analyzing information on suspected adverse reactions to medicines which have been authorized or being studied in clinical trials in the European Economic Area (EEA)...
April 17, 2023: Minerva urology and nephrology
https://read.qxmd.com/read/36999443/efficacy-of-antihypertensive-drugs-of-different-classes-after-renal-denervation-in-spontaneously-hypertensive-rats
#44
JOURNAL ARTICLE
Mathias Hohl, Lucas Lauder, Özlem Sevimli, Mert Tokcan, Lea Wagmann, Felix Götzinger, Clara Schneider, Ulrich Hübner, Ulrike Lehnert, Markus R Meyer, Michael Böhm, Felix Mahfoud
BACKGROUND: Renal denervation (RDN) lowers blood pressure (BP) in patients with uncontrolled hypertension. Limited data exist on the effectiveness of different antihypertensive medications following RDN on BP and maladaptive cardiac phenotypes. METHODS: Eighty-nine male spontaneously hypertensive rats with continuous BP recording underwent RDN or sham operation. Ten days postsurgery, spontaneously hypertensive rats were randomized to receive no antihypertensive medication, amlodipine, olmesartan, hydrochlorothiazide, bisoprolol, doxazosin, or moxonidine for 28 days...
March 31, 2023: Hypertension
https://read.qxmd.com/read/36977996/a-case-report-of-an-atypical-haemolytic-uremic-syndrome-in-pregnancy-something-wicked-this-way-comes
#45
JOURNAL ARTICLE
Stefano Catarci, Bruno Antonio Zanfini, Mariangela Di Muro, Emanuele Capone, Luciano Frassanito, Maria Teresa Santantonio, Gaetano Draisci
BACKGROUND: Atypical Haemolytic Uremic Syndrome is an acute life-threatening condition, characterized by the clinical triad of microangiopathic hemolytic anaemia, thrombocytopenia, kidney injury. Management of pregnants affected by Atypical Haemolytic Uremic Syndrome can be a serious concern for obstetric anesthesiologist in the delivery room and in the intensive care unit. CASE PRESENTATION: A 35-year-old primigravida with a monochorionic diamniotic twin pregnancy, presented with an acute haemorrhage due to retained placenta after elective caesarean section and underwent surgical exploration...
March 28, 2023: BMC Anesthesiology
https://read.qxmd.com/read/36943603/anti-cell-proliferative-mechanism-of-doxazosin-on-human-oral-cancer-cells-through-the-modulation-of-antioxidant-and-apoptotic-pathway
#46
JOURNAL ARTICLE
Dayuan Xing, Li Li, Di Meng, Yanhui Zhang, Feng Ma
Oral squamous cell carcinoma (OSCC), a global threatening disease, is reported mostly in the middle and elderly male population. Even though the exact cause of OSCC was not known, consumption of tobacco in any form has been reported in most of OSCC patients. OSCC is a massive invasive type of cancer which easily spreads to the distant organs. Hence treating it at appropriate time is necessary and the rate of OSCC incidence is also constantly increasing. At present, chemoradiation is the only therapy prescribed for OSCC patients which renders various side effects...
March 21, 2023: Applied Biochemistry and Biotechnology
https://read.qxmd.com/read/36911021/meta-analysis-of-the-efficacy-and-adverse-drug-reactions-of-adrenergic-alpha-antagonists-in-treating-children-with-ureteral-calculi
#47
REVIEW
Kai Sun, Peizhi Zhang, Yanning Sun, Qingliang Wang, Qinghua Xia
This meta-analysis investigated the efficacy and adverse drug reactions (ADRs) of three different adrenergic alpha-antagonists during the treatment of pediatric ureteral stones. Studies were retrieved from MEDLINE, EMBASE, and the Cochrane Controlled Trial Registry until January 2022. We identified 7 articles, including six RCTs and one cohort study. 610 children received either adrenergic alpha-antagonists or placebo. The results confirmed that the three different adrenergic alpha-antagonists could significantly increase the ureteral calculi expulsive rate and shorten the ureteral calculi expulsive time, regardless of the size of the stone "<5 mm" or "5-10 mm"...
2023: Frontiers in Pediatrics
https://read.qxmd.com/read/36883885/a-double-blind-randomized-controlled-trial-of-doxazosin-for-co-occurring-ptsd-and-alcohol-use-disorder-in-veterans
#48
RANDOMIZED CONTROLLED TRIAL
Sudie E Back, Julianne C Flanagan, Jim Mintz, Kathleen T Brady, Jennifer Jones, Amber M Jarnecke, Jane E Joseph, David W Shirley, Robert J Malcolm, Mark Hamner, Brett T Litz, Barbara L Niles, Stacey Young-McCaughan, Terence M Keane, Alan L Peterson
Objective: The aim of this study was to determine the efficacy of doxazosin, an α1 -adrenergic antagonist, for the treatment of co-occurring posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD). Methods: This 12-week, double-blind, randomized controlled trial of doxazosin (16 mg/d) was conducted between June 2016 and December 2019 at the Ralph H. Johnson VA Medical Center in Charleston, South Carolina. Participants were military veterans (N = 141) who met DSM-5 criteria for current PTSD and AUD and were randomly assigned to receive doxazosin (n = 70) or placebo (n = 71)...
March 8, 2023: Journal of Clinical Psychiatry
https://read.qxmd.com/read/36864060/glycolysis-enhancing-%C3%AE-1-adrenergic-antagonists-modify-cognitive-symptoms-related-to-parkinson-s-disease
#49
JOURNAL ARTICLE
Matthew A Weber, Kartik Sivakumar, Ervina E Tabakovic, Mayu Oya, Georgina M Aldridge, Qiang Zhang, Jacob E Simmering, Nandakumar S Narayanan
Terazosin is an α1 -adrenergic receptor antagonist that enhances glycolysis and increases cellular ATP by binding to the enzyme phosphoglycerate kinase 1 (PGK1). Recent work has shown that terazosin is protective against motor dysfunction in rodent models of Parkinson's disease (PD) and is associated with slowed motor symptom progression in PD patients. However, PD is also characterized by profound cognitive symptoms. We tested the hypothesis that terazosin protects against cognitive symptoms associated with PD...
March 2, 2023: NPJ Parkinson's Disease
https://read.qxmd.com/read/36847075/exploring-the-repurposing-potential-of-telmisartan-drug-in-breast-cancer-an-in-silico-and-in-vitro-approach
#50
JOURNAL ARTICLE
Urwashi Kumar, Jyotirmoi Aich, Shine Devarajan
Anticancer drug resistance is one of the biggest hurdles in the treatment of breast cancer. Drug repurposing is a viable option fordeveloping novel medical treatment strategies since this method is more cost-efficient and rapid. Antihypertensive medicines have recently been found to have pharmacological features that could be used to treat cancer, making them effective candidates for therapeutic repurposing. The goal of our research is to find a potent antihypertensive drug that can be repurposed as adjuvant therapy for breast cancer...
February 24, 2023: Anti-cancer Drugs
https://read.qxmd.com/read/36835945/medical-expulsive-therapy-for-pediatric-ureteral-stones-a-meta-analysis-of-randomized-clinical-trials
#51
REVIEW
Pardis Ziaeefar, Abbas Basiri, Moein Zangiabadian, Jean de la Rosette, Homayoun Zargar, Maryam Taheri, Amir H Kashi
To evaluate the efficacy and safety of medical expulsive therapy (MET) for ureteral stones in pediatric patients, Cochrane, PubMed, Web of Science, Scopus, and the reference list of retrieved studies were searched up to September 2022 to identify RCTs on the efficacy of MET. The protocol was prospectively registered at PROSPERO (CRD42022339093). Articles were reviewed, data were extracted by two reviewers, and the differences were resolved by the third reviewer. The risk of bias was assessed using the RoB2...
February 10, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/36826975/neuroimmunomodulation-of-adrenoblockers-during-liver-cirrhosis-modulation-of-hepatic-stellate-cell-activity
#52
REVIEW
Mariana Yazmin Medina Pizaño, María de Jesús Loera Arias, Roberto Montes de Oca Luna, Odila Saucedo Cárdenas, Javier Ventura Juárez, Martin Humberto Muñoz Ortega
The sympathetic nervous system and the immune system are responsible for producing neurotransmitters and cytokines that interact by binding to receptors; due to this, there is communication between these systems. Liver immune cells and nerve fibres are systematically distributed in the liver, and the partial overlap of both patterns may favour interactions between certain elements. Dendritic cells are attached to fibroblasts, and nerve fibres are connected via the dendritic cell-fibroblast complex. Receptors for most neuroactive substances, such as catecholamines, have been discovered on dendritic cells...
December 2023: Annals of Medicine
https://read.qxmd.com/read/36826466/development-of-a-machine-learning-based-predictive-model-for-prediction-of-success-or-failure-of-medical-management-for-benign-prostatic-hyperplasia
#53
JOURNAL ARTICLE
Kyle Pham, Al W Ray, Austin J Fernstrum, Anood Alfahmy, Soumya Ray, Adonis K Hijaz, Mingxuan Ju, David Sheyn
OBJECTIVE: To develop a novel predictive model for identifying patients who will and will not respond to the medical management of benign prostatic hyperplasia (BPH). METHODS: Using data from the Medical Therapy of Prostatic Symptoms (MTOPS) study, several models were constructed using an initial data set of 2172 patients with BPH who were treated with doxazosin (Group 1), finasteride (Group 2), and combination therapy (Group 3). K-fold stratified cross-validation was performed on each group, Within each group, feature selection and dimensionality reduction using nonnegative matrix factorization (NMF) were performed based on the training data, before several machine learning algorithms were tested; the most accurate models, boosted support vector machines (SVMs), being selected for further refinement...
February 24, 2023: Neurourology and Urodynamics
https://read.qxmd.com/read/36613097/the-effects-of-pharmacological-treatment-of-nightmares-a-systematic-literature-review-and-meta-analysis-of-placebo-controlled-randomized-clinical-trials
#54
REVIEW
Mathilda Skeie-Larsen, Rebekka Stave, Janne Grønli, Bjørn Bjorvatn, Ane Wilhelmsen-Langeland, Amin Zandi, Ståle Pallesen
Nightmares are highly prevalent and distressing for the sufferer, which underlines the need for well-documented treatments. A comprehensive literature review and meta-analysis of the effects of different pharmacological placebo-controlled randomized clinical trials, covering the period up to 1 December 2022, was performed. Searches were conducted in PubMed, Embase, Web of Science, PsychInfo, Cinahl, and Google Scholar, resulting in the identification of 1762 articles, of which 14 met the inclusion criteria: pharmacological intervention of nightmares, based on a placebo-controlled randomized trial published in a European language, reporting outcomes either/or in terms of nightmare frequency, nightmare distress, or nightmare intensity, and reporting sufficient information enabling calculation of effect sizes...
December 31, 2022: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/36531717/development-and-analysis-of-a-comprehensive-diagnostic-model-for-aortic-valve-calcification-using-machine-learning-methods-and-artificial-neural-networks
#55
JOURNAL ARTICLE
Tao Xiong, Yan Chen, Shen Han, Tian-Chen Zhang, Lei Pu, Yu-Xin Fan, Wei-Chen Fan, Ya-Yong Zhang, Ya-Xiong Li
BACKGROUND: Although advanced surgical and interventional treatments are available for advanced aortic valve calcification (AVC) with severe clinical symptoms, early diagnosis, and intervention is critical in order to reduce calcification progression and improve patient prognosis. The aim of this study was to develop therapeutic targets for improving outcomes for patients with AVC. MATERIALS AND METHODS: We used the public expression profiles of individuals with AVC (GSE12644 and GSE51472) to identify potential diagnostic markers...
2022: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/36420815/impact-of-the-covid-19-pandemic-on-cardiovascular-heart-disease-medication-use-time-series-analysis-of-england-s-prescription-data-during-the-covid-19-pandemic-january-2019-to-october-2020
#56
JOURNAL ARTICLE
Ravina Barrett, James Hodgkinson
BACKGROUND: Management of high blood pressure (BP) typically requires adherence to medication regimes. However, it is known that the COVID-19 pandemic both interrupted access to some routine prescriptions and changed some patient health behaviours. AIM: This study, therefore, retrospectively investigated prescription reimbursement of cardiovascular (CVD) medicines as a proxy measure for patient adherence and access to medicines during the pandemic. METHODS: A cohort study of all primary care patients in England prescribed CVD medicines...
2022: Therapeutic Advances in Cardiovascular Disease
https://read.qxmd.com/read/36400921/novel-non-stimulants-rescue-hyperactive-phenotype-in-an-adgrl3-1-mutant-zebrafish-model-of-adhd
#57
JOURNAL ARTICLE
Hildur Sóley Sveinsdóttir, Christian Christensen, Haraldur Þorsteinsson, Perrine Lavalou, Matthew O Parker, Alena Shkumatava, William H J Norton, Emile Andriambeloson, Stéphanie Wagner, Karl Ægir Karlsson
ADHD is a highly prevalent neurodevelopmental disorder. The first-line therapeutic for ADHD, methylphenidate, can cause serious side effects including weight loss, insomnia, and hypertension. Therefore, the development of non-stimulant-based therapeutics has been prioritized. However, many of these also cause other effects, most notably somnolence. Here, we have used a uniquely powerful genetic model and unbiased drug screen to identify novel ADHD non-stimulant therapeutics. We first found that adgrl3.1 null (adgrl3...
November 18, 2022: Neuropsychopharmacology
https://read.qxmd.com/read/36380803/the-enigma-of-resistant-hypertension-from-lifestyle-changes-and-pharmacological-treatment-to-renal-denervation
#58
JOURNAL ARTICLE
Massimo Volpe, Giovanna Gallo
Resistant hypertension consists in the failure to achieve effective control of blood pressure despite the use of at least three drugs, including a diuretic, at the maximum tolerated dosage. Despite the progress made in terms of improving awareness and effectiveness of the available therapeutic strategies, the percentage of patients with resistant hypertension represents up to 18% of the entire hypertensive population. The management of resistant hypertension includes the combination of different strategies from lifestyle changes to complex interventional procedures...
November 2022: European Heart Journal Supplements: Journal of the European Society of Cardiology
https://read.qxmd.com/read/36368628/impact-of-intraoperative-floppy-iris-syndrome-in-cataract-surgery-by-phacoemulsification-analysis-of-622-cases
#59
JOURNAL ARTICLE
A Herranz Cabarcos, R Pifarré Benítez, A Martínez Palmer
BACKGROUND: Small pupil syndromes, including IFIS, increase the risk of complications during cataract surgery if proper surgical planning is not performed. Tamsulosin is associated with a very significant increase in the risk of IFIS, due to the prolonged inactivation of alpha-1 adrenergic receptors in the smooth muscle fiber of the iris. MATERIAL AND METHODS: Single-center prospective observational study, carried out at the Hospital de l'Esperança - Parc de Salut Mar...
February 2023: Archivos de la Sociedad Española de Oftalmología
https://read.qxmd.com/read/36355960/inhibitory-effect-of-%C3%AE-1-receptor-antagonists-on-paclitaxel-induced-peripheral-neuropathy-in-a-rodent-model-and-clinical-database
#60
JOURNAL ARTICLE
Kohei Mori, Takehiro Kawashiri, Keisuke Mine, Mizuki Inoue, Hibiki Kudamatsu, Mayako Uchida, Nobuaki Egashira, Daisuke Kobayashi, Takao Shimazoe
The anticancer drug, paclitaxel, is widely used for ovarian, breast, non-small cell lung, and gastric cancers; however, it induces peripheral neuropathy as a side effect. There is insufficient evidence-based prophylaxis, and new prophylaxis and treatment methods are required. We examined the effect of α1-receptor antagonists on paclitaxel-induced peripheral neuropathy using Sprague-Dawley rats and a large adverse event database. The repeated administration of doxazosin or tamsulosin significantly reduced the response threshold to paclitaxel administration in animal models...
November 6, 2022: Toxics
keyword
keyword
111040
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.